Document is current

Any future updates will be listed below

Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database

Crossref DOI link: https://doi.org/10.1007/s40264-025-01552-7

Published Online: 2025-04-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark